Literature DB >> 17313304

Cervical surgery and preterm birth.

Lynn Sadler1, Audrey Saftlas.   

Abstract

Treatment of cervical intraepithelial neoplasia (CIN) greatly reduces the risk of cervical cancer. Treatment involves ablation or excision of the transformation zone of the cervix, most commonly using an electrosurgical excision technique known as LLETZ. However, the peak incidence of CIN occurs in young women, so if excision of a portion of the cervix has an adverse effect on pregnancy outcome, this might have a significant impact. This review discusses the methodology and findings of the published literature on the association between cervical treatment and preterm birth, and the clinical implications of these findings.

Entities:  

Mesh:

Year:  2007        PMID: 17313304     DOI: 10.1515/JPM.2007.001

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  10 in total

1.  Clinical significance of early (< 20 weeks) vs. late (20-24 weeks) detection of sonographic short cervix in asymptomatic women in the mid-trimester.

Authors:  E Vaisbuch; R Romero; O Erez; J P Kusanovic; S Mazaki-Tovi; F Gotsch; V Romero; C Ward; T Chaiworapongsa; P Mittal; Y Sorokin; S S Hassan
Journal:  Ultrasound Obstet Gynecol       Date:  2010-10       Impact factor: 7.299

2.  Adherence to conservative management recommendations for abnormal pap test results in adolescents.

Authors:  Rebecca B Perkins; Jennifer R Jorgensen; Molly E McCoy; Sharon M Bak; Tracy A Battaglia; Karen M Freund
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

3.  Pregnancy outcome after cervical conization: risk factors for preterm delivery and the efficacy of prophylactic cerclage.

Authors:  Ka Hyun Nam; Ja Young Kwon; Young-Han Kim; Yong-Won Park
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

Review 4.  Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Kypros Nicolaides; Tinnakorn Chaiworapongsa; John M O'Brien; Elcin Cetingoz; Eduardo da Fonseca; George Creasy; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

5.  Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women.

Authors:  Jacqueline M Hirth; Alai Tan; Gregg S Wilkinson; Abbey B Berenson
Journal:  Am J Obstet Gynecol       Date:  2013-05-30       Impact factor: 8.661

6.  Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.

Authors:  Koenraad Van Doorslaer; Laura L Reimers; Yevgeniy Y Studentsov; Mark H Einstein; Robert D Burk
Journal:  Gynecol Oncol       Date:  2009-06-24       Impact factor: 5.482

Review 7.  Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.

Authors:  M Arbyn; M Kyrgiou; C Simoens; A O Raifu; G Koliopoulos; P Martin-Hirsch; W Prendiville; E Paraskevaidis
Journal:  BMJ       Date:  2008-09-18

Review 8.  Cyclooxygenase-1 and -2: molecular targets for cervical neoplasia.

Authors:  Hee Seung Kim; Taehun Kim; Mi-Kyung Kim; Dong Hoon Suh; Hyun Hoon Chung; Yong Sang Song
Journal:  J Cancer Prev       Date:  2013-06

9.  The impact of cervical conization size with subsequent cervical length changes on preterm birth rates in asymptomatic singleton pregnancies.

Authors:  Sergei V Firichenko; Michael Stark; Ospan A Mynbaev
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

10.  The amniotic fluid cell-free transcriptome in spontaneous preterm labor.

Authors:  Gaurav Bhatti; Roberto Romero; Nardhy Gomez-Lopez; Roger Pique-Regi; Percy Pacora; Eunjung Jung; Lami Yeo; Chaur-Dong Hsu; Mahendra Kavdia; Adi L Tarca
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.